ID 689811 - BioProject

Format

Choose Destination

Accession: PRJNA689811 ID: 689811

SARS CoV-2 WGS

Navigate Up

This project is a component of the COVID-19 Outbreak

Navigate Across

59 additional projects are components of the COVID-19 Outbreak.

962 additional projects are components of the INSDC SARS-CoV-2 Viral Sequencing Data.

Whole genome sequencing of SARS CoV-2 from New York State performed by the Wadsworth Center.

Accession	PRJNA689811
Data Type	Genome sequencing
Scope	Multispecies
Submission	Registration date: 5-Jan-2021 Wadsworth Center
Relevance	Medical

Project Data:

Parameter	Value
Data volume, Mbases	74
Data volume, Mbytes	38

Supplemental Content

Severe acute respiratory syndrome coronavirus 2
Severe acute respiratory syndrome coronavirus 2
SARS-CoV-2 Whole-Genome Sequencing

BioProject
Severe acute respiratory syndrome coronavirus 2 strain:Gamma
Severe acute respiratory syndrome coronavirus 2 strain:Gamma
Severe acute respiratory syndrome coronavirus 2 strain:Gamma Raw sequence reads

BioProject
SARS-CoV-2 point mutation and deletion spectra, and their association with diffe...
SARS-CoV-2 point mutation and deletion spectra, and their association with different disease outcome
The study shows that mutant spectra of SARS-CoV-2 from diagnostic samples differed in point mutation abundance and complexity, and that significantly larger values were recorded in virus from patients who developed mild COVID-19 symptoms. The abundance of low frequency mutations marks a difference with other RNA viruses, and it may slow down the response of SARS-CoV-2 to escape specific selective constraints such as drugs or antibodies.

BioProject
undefined
undefined
A comparison of high-throughput SARS-CoV-2 sequencing methods using COVID-19 patient samples

BioProject

Your browsing activity is empty.

Activity recording is turned off.